Haemonetics (HAE) Misses Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Oil market losses easing as nearly 80% of disrupted supply returns, UBS says
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Barrington Research Downgrades Haemonetics (HAE) to Market Perform
August 3, 2016 8:02 AM EDTBarrington Research downgraded Haemonetics (NYSE: HAE) from Outperform to Market Perform and removed its price target (prior $32.00).
For an analyst ratings summary and ratings history on Haemonetics click here. For more ratings news on Haemonetics click here.
Shares of Haemonetics closed at $34.50 yesterday.
... MoreHaemonetics (HAE) PT Raised to $40 at Jefferies
August 2, 2016 7:20 AM EDTJefferies analyst Anthony Petrone reiterated a Buy rating and raised his price target on Haemonetics (NYSE: HAE) to $40.00 (from $32.00) following mixed Q1 with $3mn top-line beat offset by a $0.03 EPS miss,
commented, "Underlying growth trends in Plasma and TEG were as expected and... More
